Overall verdict
Neutral
6.1/10
1-year performance
+3.72%
Score breakdown
Up 3.7% over 1 year, 40% of the 52-week range.
Strongest: Financial strength 9.5/10. Weakest: Growth 3.5/10.
16 analysts, target +0.1% vs the price.
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, and foreign exchange; and agricultural, energy, and metals commodities, as well as fixed income and foreign currency trading services. The company provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges.
In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. CME Group Inc. partners with FutureSports to futures on sports indexes.
The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.
Sector
Financials
Industry
Capital Markets
Primary listing
Nasdaq
United States
CEO
Terrence Duffy
Founded
1898
Employees
3 875
Revenue / employee
1.7M USD
Next earnings
October 21, 2026
Institutional holders
- BlackRock, Inc.8.24%
- VANGUARD CAPITAL MANAGEMENT LLC6.38%
- STATE STREET CORP4.40%
- MORGAN STANLEY2.62%
- GEODE CAPITAL MANAGEMENT, LLC2.50%
- VANGUARD PORTFOLIO MANAGEMENT LLC2.47%
- Capital World Investors1.84%
- JPMORGAN CHASE & CO1.55%
- Sanders Capital, LLC1.37%
- Other institutions55.00%
- Rest of the register13.64%
1699 13F filings as of June 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
329.16 USD
52-week low
218.31 USD
1-year performance
3.72%
Rising
Year-to-date performance
-0.53%
Rising
Drawdown
-20.29%
Marked drawdown
Position in the 52-week range
40% of range
Against the world ETF
Over 17 years, from September 2009 to August 2026, the share did not do better than the world ETF once risk is accounted for. It earned more, but shaking 1.7 times harder: for the risk taken, the ETF paid better.
10,000 € placed at the end of September 2009 are worth today
| CME Group | 113 047 € |
| World ETF | 74 620 € |
| S&P 500 | 123 025 € |
| Risk-free placement | 11 288 € |
The risk
- Shaking:the share moves 1.7 times as much as the world ETF.
- Worst fall:-37 % between February 2020 and November 2020. 10,000 € placed at the top fell to 6 350 €. The world ETF, at worst: -34 %. Back to its high in 12 months.
CME Group earned more than the world ETF since 2009
Value of 10,000 euros placed at the end of September 2009, dividends reinvested, in euros
- CME Group: 113 047 €
- World ETF: 74 620 €
- S&P 500: 123 025 €
- Risk-free placement: 11 288 €
Based on past performance. This is not a recommendation.
Range: 230.00 USD - 271.71 USD (3 methods agree)
The price implies growth of 6.89% per year; the company grows at 13.70%.
Gross margin 82.7%, net margin 63.3%, ROIC 13.9%, ROE 15.8%.
Net margin
63.28%
Exceptional
Sector 26.90%|S&P 12.97%
Gross margin
82.65%
Fair
Return on equity (ROE)
15.80%
Fair
Sector 18.14%|S&P 16.52%
Return on invested capital (ROIC)
13.87%
Fair
Free cash flow margin (FCF)
62.20%
Exceptional
Profit-to-cash conversion (FCF conversion)
0.98x
Fair
Margin stability
2.9 pts
Steady
Revenue to net income
Growth
3.5/10Revenue up 0.8% over 1 year, 6.0% a year over 5, EPS 13.7% a year over 5.
Revenue (trailing 12 months)
6.8Md USD
Revenue growth (1y)
0.84%
Moderate
Revenue growth (3y)
29.91%
Solid
EPS growth (1y)
2.66%
Moderate
EPS CAGR (5y)
13.70%
Fair
EPS revisions (3 months)
-0.20%
Revised down
Valuation
5.9/10P/E 22.3x, forward P/E 22.2x, EV/EBITDA 20.9x, PEG 1.62. The multiple sits in the 20th percentile of its own 5-year history.
P/E (TTM)
22.3x
Fair
Sector 24.4x|S&P 23.0x
Forward P/E
22.2x
Fair
EV / EBITDA
20.9x
Expensive
Sector 15.3x|S&P 14.5x
PEG
1.62
Expensive
Sector 0.56|S&P 0.86
Fair value (reverse DCF)
234.58 USD
Overvalued
P/E vs its own 5-year history
among the 20% lowest valuations
Far cheaper than usual
Market cap
97.4Md USD
Financial strength
9.5/10Cash covers 58.9% of the debt, net debt/EBITDA -0.2x.
Net debt / EBITDA
-0.2x
Very solid
Gearing (net debt / equity)
5.99%
Very solid
Cash
2.3Md USD
Cash / market cap
2.34%
Stretched
Cash / total debt
58.94%
Solid
Net debt
1.6Md USD
Equity
26.5Md USD
Closed daily candles, 2 years
Last close on September 24, 2026: 268.91 USD
- MM20277.00
- MM50268.44
- MM200278.64
- RSI 1445.2
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
-0.00%
200-day average slope, 3 months
-0.87%
50-day average slope, 1 month
+6.25%
Price structure
higher-low
Bullish RSI divergence
No
20-day volatility
1.41 % per day
Volatility change
-14.33%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 11.80 (4) | 12.25 (15) | 7 026 (13) | 5 009 (7) | 4 389 (1) |
| 2027 | 12.56 (4) | 12.93 (15) | 7 354 (13) | 5 226 (7) | 4 425 (1) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of September 15, 2026.
Same sub-industry: 56 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DB1 | 7.2 | 7.1 | 57.1Md USD | 24.4x | 27.2 % | 149.8 % | 12.7 % | -2.8x | 5.8 % | 28.4 % | ||
| 2 | 388 | 7.1 | 7.8 | 63.8Md USD | 25.2x | 62.3 % | 17.7 % | 33.3 % | -12.5x | — | -11.1 % | ||
| 3 | MCO | 6.4 | 6.1 | 82.1Md USD | 30.0x | 34.3 % | 15.1 % | 26.6 % | 1.2x | 3.6 % | -1.3 % | ||
| 4 | CME | 6.1 | 6.1 | 97.4Md USD | 22.3x | 63.3 % | 0.8 % | 13.9 % | -0.2x | 4.3 % | 3.7 % | ||
| 5 | SPGI | 5.9 | 5.6 | 120Md USD | 24.8x | 30.5 % | 10.4 % | 11.0 % | 1.6x | 4.7 % | -13.4 % | ||
| 6 | ICE | 5.5 | 5.0 | 87.8Md USD | 22.1x | 30.7 % | 6.8 % | 8.5 % | 2.7x | 5.8 % | -6.3 % | ||
| 7 | LSEG | 5.2 | 5.4 | 52.9Md USD | 29.9x | 14.6 % | 5.0 % | 4.9 % | 1.7x | 9.5 % | 0.6 % | ||
| 8 | NDAQ | 5.2 | 4.8 | 53.3Md USD | 27.8x | 22.6 % | 20.5 % | 9.4 % | 2.8x | 3.7 % | 6.9 % | ||
| 9 | COIN | 4.2 | 2.8 | 53.0Md USD | Not meaningful (loss) | -20.6 % | -60.9 % | -5.7 % | -3.7x | 3.2 % | -38.5 % |
